Scarica l'app Stockscreener
6.3827
0.92%
-0.1073
Dopo l'orario di chiusura:
6.35
-0.0327
-0.51%
Precedente Chiudi:
$6.49
Aprire:
$6.5
Volume 24 ore:
4,794
Relative Volume:
0.20
Capitalizzazione di mercato:
$58.02M
Reddito:
$23.84M
Utile/perdita netta:
$-3.81M
Rapporto P/E:
-12.77
EPS:
-0.5
Flusso di cassa netto:
$-713.00K
1 W Prestazione:
+0.16%
1M Prestazione:
+22.01%
6M Prestazione:
+37.10%
1 anno Prestazione:
+53.83%
Intervallo 1D:
$6.27
$6.5771
Intervallo di 1 settimana:
$6.1429
$6.5771
Portata 52W:
$3.34
$7.0063
Immucell Corp Stock (ICCC) Company Profile
Nome
Immucell Corp
Settore
Industria
Telefono
(207) 878-2770
Indirizzo
56 EVERGREEN DR, PORTLAND, ME
Confronta ICCC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.3827 | 58.02M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.91 | 114.57B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
522.83 | 55.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.78 | 39.64B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
551.12 | 35.64B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
264.42 | 28.55B | 3.81B | -644.79M | -669.77M | -6.24 |
Immucell Corp Borsa (ICCC) Ultime notizie
Immucell director Bryan Gathagan acquires $6,320 in shares By Investing.com - Investing.com India
Immucell director Bryan Gathagan acquires $6,320 in shares - Investing.com
ImmuCell expands First Defense team - Feedstuffs
Citadel Advisors LLC Invests $149,000 in ImmuCell Co. (NASDAQ:ICCC) - Defense World
ImmuCell stock soars to 52-week high, touches $7 mark - Investing.com
Northern Trust Corp Increases Stake in ImmuCell Co. (NASDAQ:ICCC) - Defense World
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World
ImmuCell stock soars to 52-week high, touches $5.97 By Investing.com - Investing.com Canada
ImmuCell stock soars to 52-week high, touches $5.97 - Investing.com
ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains - Yahoo Finance
ImmuCell Reports Y/Y Q1 Earnings Growth On Record Sales & Margin Gains - Barchart.com
Dimensional Fund Advisors LP Has $341,000 Stock Position in ImmuCell Co. (NASDAQ:ICCC) - Defense World
ImmuCell Corporation (NASDAQ:ICCC) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ImmuCell’s Q1 2025 revenue hits record, stock surges - Investing.com
ImmuCell Q2 2025 slides: sales momentum continues as Re-Tain awaits FDA approval - Investing.com Canada
ImmuCell Corp Q1 2025 Earnings: EPS at $0.16, Revenue Hits $8.1 Million - GuruFocus
ImmuCell Corporation Q1 2025 Financial Results - TradingView
ImmuCell To Announce Unaudited Financial Results For the Quarter Ended March 31, 2025 - Barchart.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 - Stock Titan
Geode Capital Management LLC Boosts Stock Holdings in ImmuCell Co. (NASDAQ:ICCC) - Defense World
ImmuCell Co. (NASDAQ:ICCC) Short Interest Update - Defense World
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell reports record sales in first quarter of 2025 - Investing.com
Record Quarter: ImmuCell Crushes Sales Estimates with $8.1M Revenue Milestone - Stock Titan
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 - The Globe and Mail
ImmuCell appoints new CFO to bolster growth strategy - Investing.com
ImmuCell Strengthens Leadership: 24-Year IDEXX Finance Expert Takes CFO Role - Stock Titan
ImmuCell Hires Chief Financial Officer - The Globe and Mail
ImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance
Revolutionary Antibiotic-Free Mastitis Treatment Enters Market Testing Phase - Stock Titan
IMMUCELL CORP /DE/ SEC 10-K Report - TradingView
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – Time to Sell? - Defense World
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
ImmuCell Corp. to Host Earnings Call - ACCESS Newswire
ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval for Re-Tain - Yahoo Finance
ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... By GuruFocus - Investing.com Canada
ImmuCell Corporation (NASDAQ:ICCC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ImmuCell sees strong Q4 2024 sales growth - Investing.com
ImmuCell Corporation Reports Strong Financial Performance for Q4 and Full Year 2024 - TradingView
Animal Health Pioneer ImmuCell Sets Stage for Critical Year-End Financial Reveal - StockTitan
The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell - Yahoo Finance
Top Stock Reports for Apple, Eli Lilly & Shopify - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell Settles Insurance Claim for Production Contamination Events - Defense World
ImmuCell settles insurance claim for production losses - Investing.com
ImmuCell Secures $426,587 Additional Insurance Settlement for Production Contamination Issues - StockTitan
Immucell Corp Azioni (ICCC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.04%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):